JW Shinyak Corp
JW CreaGene is committed to ethical standards and compliance, aiming to contribute to society through sincere and fair corporate activities. The company emphasizes customer satisfaction, legal compliance, fair competition, protection of personal information, and innovation in healthcare and pharmaceuticals. It is part of the JW Group, which is dedicated to global health care development and innovative drug research.
Industries
Nr. of Employees
large (251-1000)
JW Shinyak Corp
JW Tower, 38, Gwacheon-daero 7-gil, Gwacheon-si, Gyeonggi-do, 13840, Republic of Korea
Products
Clinical-stage autologous dendritic cell therapeutic vaccines
Autologous DC-based therapeutic vaccines using patient-derived material and tumor antigens; clinical programs listed across indications including glioblastoma, hepatocellular carcinoma and renal cell carcinoma.
Bench-top automated chemiluminescent POCT analyzer (single-cartridge)
Compact, fully automated immunoassay analyzer designed for point-of-care quantitative chemiluminescent measurements with single-test cartridges and multiple parallel assays within ~20 minutes.
Diagnostic kits for sepsis and pancreatic cancer biomarkers
In vitro diagnostic kits based on protein biomarkers (example biomarkers: WRS for sepsis; complement factor B combined with CA19-9 for pancreatic cancer) and associated antibodies.
Nutrition multi-chamber IV solutions and non-PVC container products
Parenteral nutrition products including multi-chamber bags (2- and 3-chamber), lipid emulsions and amino-acid formulations supplied in non‑PVC films and PP containers.
Carbapenem API manufacturing capability
Manufacture and purification capabilities for carbapenem class APIs (imipenem, meropenem, doripenem) using high-pressure hydrogenation and Prep-HPLC; regulatory dossier work for ertapenem.
Clinical-stage autologous dendritic cell therapeutic vaccines
Autologous DC-based therapeutic vaccines using patient-derived material and tumor antigens; clinical programs listed across indications including glioblastoma, hepatocellular carcinoma and renal cell carcinoma.
Bench-top automated chemiluminescent POCT analyzer (single-cartridge)
Compact, fully automated immunoassay analyzer designed for point-of-care quantitative chemiluminescent measurements with single-test cartridges and multiple parallel assays within ~20 minutes.
Diagnostic kits for sepsis and pancreatic cancer biomarkers
In vitro diagnostic kits based on protein biomarkers (example biomarkers: WRS for sepsis; complement factor B combined with CA19-9 for pancreatic cancer) and associated antibodies.
Nutrition multi-chamber IV solutions and non-PVC container products
Parenteral nutrition products including multi-chamber bags (2- and 3-chamber), lipid emulsions and amino-acid formulations supplied in non‑PVC films and PP containers.
Carbapenem API manufacturing capability
Manufacture and purification capabilities for carbapenem class APIs (imipenem, meropenem, doripenem) using high-pressure hydrogenation and Prep-HPLC; regulatory dossier work for ertapenem.
Services
Formulation, sterile filling, packaging and supply of IV/nutrition solutions and associated container closure systems including non‑PVC multi-chamber bags.
Antibody screening and immunoassay development services to support biomarker validation and diagnostic kit development.
Process development and manufacturing support for autologous cell therapies including antigen production and DC manufacturing workflows.
Structured partnerships and licensing, including joint research with academic centers for biomarker discovery and diagnostic technology transfer.
Formulation, sterile filling, packaging and supply of IV/nutrition solutions and associated container closure systems including non‑PVC multi-chamber bags.
Antibody screening and immunoassay development services to support biomarker validation and diagnostic kit development.
Process development and manufacturing support for autologous cell therapies including antigen production and DC manufacturing workflows.
Structured partnerships and licensing, including joint research with academic centers for biomarker discovery and diagnostic technology transfer.
Expertise Areas
- Dendritic cell immunotherapy development
- Biomarker discovery and diagnostic kit development
- Immunoassay and point-of-care diagnostics
- Small-molecule discovery and peptide-mimetic screening
Key Technologies
- Dendritic cell vaccine methods
- Cytoplasmic transduction peptide (CTP) delivery
- Chemiluminescent immunoassay (CLIA)
- Point-of-care immunoanalyzer (single-cartridge)